Prognostic Utility of Microvolt T-Wave Alternans in Risk Stratification of Patients With Ischemic Cardiomyopathy
Theodore Chow, MD, FACC*,
Dean J. Kereiakes, MD, FACC*,
Cheryl Bartone, RN*,
Terri Booth, RN*,
Edward J. Schloss, MD, FACC*,
Theodore Waller, MD, FACC*,
Eugene S. Chung, MD*,
Santosh Menon, MD*,
Brahmajee K. Nallamothu, MD, MPH and
Paul S. Chan, MD, MSc ,*
* The Lindner Clinical Trial Center at the Christ Hospital and the Ohio Heart & Vascular Center, Cincinnati, Ohio
VA Health Services Research & Development and University of Michigan Medical School, Ann Arbor, Michigan

View larger version (10K):
[in a new window]
|
Figure 1 Kaplan-Meier survival curves for all-cause mortality for the study population stratified by defibrillator status.
|
|
|